
|
NEWS SERVICES
210 Pittsboro Street, Campus Box 6210
Chapel Hill, NC 27599-6210
(919) 962-2091 FAX: (919) 962-2279
www.unc.edu/news/
|
NEWS
| For immediate use |
April 29, 2003 -- No. 253 |
Seed grants to support research on ovarian cancer, melanoma, other
cancers
By AMY PHILBECK
UNC Lineberger Comprehensive Cancer Center
CHAPEL HILL -- The University of North Carolina at Chapel
Hill’s Lineberger Comprehensive Cancer Center has awarded seven seed grants
worth a total of $197,500 for new studies in cancer research.
Funding has been provided by grants from businesses, charitable foundations
and individuals. They support new and growing research projects in innovative
areas, helping to launch smaller projects that could lead to more in-depth
studies in the future.
Of the seven grants, six aim to translate laboratory findings into potential
clinical use. The remaining study looks at cancer epidemiology.
Following are the newly funded projects, awarded to faculty in various School
of Medicine departments:
- Dr. Christine Chung, postdoctoral fellow in the division of
hematology and oncology, will use the relatively new technology of
microarray analysis to better understand the changes in a patient’s body
that lead to head and neck cancers. She will look specifically at gene
patterns to identify how they relate to tumor behavior.
- Dr. Ruth Lininger, assistant professor in the department of
pathology and laboratory medicine, ultimately hopes her lab’s research may
identify a gene that could be used in the future to screen for endometrial
cancer in a non-invasive test during a routine gynecologic exam, as well as
identify genes that may be targets for endometrial cancer treatment.
- Dr. Andrew Morris, an associate professor in the department of cell
and developmental biology, and Dr. Linda Van Le, associate professor
in the department of obstetrics and gynecology, will focus specifically on
therapeutic targets for ovarian cancer due to the current lack of effective
therapies. Morris and Van Le believe a particular lipid common in the blood
of ovarian cancer patients may be a potential target for future
treatments.
- Dr. Nancy Thomas, clinical associate professor in the department of
dermatology, is looking at melanoma, which results from a little-understood
combination of multiple genetic defects. She will examine a specific gene
commonly mutated in melanoma patients in hopes that it will lead to the
design of more effective treatments for melanoma and help identify how
different patients would respond to specific treatments.
- Dr. Charles Perou, an assistant professor of genetics, and Dr.
Christoph Borchers, an assistant professor of biochemistry, plan to
focus on characterizing the diversity of human breast tumors using
proteomics and microarrays. These complementary approaches are expected to
yield new biological insights into breast tumor biology, which could result
in the identification of new subtypes of breast tumors with clinical
importance.
- Dr. Benjamin Calvo, associate professor and chief of the division
of surgical oncology, and Dr. Bert O’ Neill, assistant professor in
the division of medical oncology, will focus how to better determine a tumor’s
response to treatment. O’Neil and Calvo will study methods to better
predict which tumors will respond favorably to a given treatment program.
These technologies will be key in light of the ever-increasing number of
therapies available to treat a given tumor type.
- Dr. David Ransohoff, professor in the department of medicine, is
particularly interested in the development and implementation of cancer
screening policy. He is involved in research to assess, on a statewide
level, the overall use of colonoscopy in screening for colon cancer and in
surveillance after removal of colon polyps.
Businesses, charitable foundations and individuals contributing to the center’s
seed grant initiative are the A.E. Finley Foundation and the John William Pope
Foundation, both of Raleigh; the A.W. McAlister Foundation and the Foundation of
the Carolinas, both of Charlotte; the Brody Brothers’ Foundation and the
Schechter Foundation of Kinston; the Brown W. Finch Foundation of Winston-Salem;
the Carter Foundation and the Cemala Foundation of Greensboro; the Florence
Rogers Charitable Trust of Fayetteville; the Ladies Auxiliary VFW of Norlina;
Richard Byron Lupton of Worthington, Ohio; and the Neisler Foundation of Kings
Mountain.
- 30 -
Lineberger center contact: Dianne G. Shaw, (919) 966-5905 or dgs@med.unc.edu